XML 74 R64.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Per Share - Narrative (Details) - $ / shares
3 Months Ended
Apr. 07, 2022
Dec. 07, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Feb. 11, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Options outstanding (in shares)     893,986   482,000  
Weighted-average exercise price average exercise price (in usd per share)     $ 8.57   $ 9.99  
Exercise price (usd per shares)     $ 11.50      
Debt conversion, converted instrument, shares issued (in shares)   17,391,304 17,931,304      
Debt instrument, convertible, conversion price (in usd per shares)   $ 11.50 $ 11.50      
Antidilutive shares (in shares)       0    
Common Stock | ProModel | Subsequent Event            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Units issued to acquiree (in shares) 649,976          
Restricted Stock Units (RSUs)            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Shares outstanding (in shares)     3,148,274      
Performance Shares            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Shares outstanding (in shares)     150,000      
Private warrants            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Number of securities called by warrant (in shares)     366,533      
Exercise price (usd per shares)     $ 11.50   $ 11.50  
Public Warrants            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Number of securities called by warrant (in shares)     11,959,939     1
Exercise price (usd per shares)           $ 11.50